Latest News and Press Releases
Want to stay updated on the latest news?
-
Á aðalfundi Kviku sem haldinn var þann 18. mars 2026 var samþykkt að lækka hlutafé félagsins um 301.000.000 kr. að nafnvirði, eða sem nemur 301.000.000 hlutum, úr 4.631.000.000 kr. í 4.330.000.000 kr....
-
At Kvika's AGM held on 18 March 2026 the meeting approved to reduce the company's share capital by ISK 301,000,000 nominal value, or the equivalent of 301,000,000 shares, from ISK 4,631,000,000 to ISK...
-
DirectBooking investors endorse six resolutions reshaping capital and voting control.
-
STAMFORD, Conn., March 26, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its Board...
-
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed...
-
BEIJING, March 26, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...
-
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (the "Company")...
-
CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
-
HOUSTON, March 25, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the...